Evaluation of the exposure equivalence of oral versus intravenous temozolomide.
Diez BD, Statkevich P, Zhu Y, Abutarif MA, Xuan F, Kantesaria B, Cutler D, Cantillon M, Schwarz M, Pallotta MG, Ottaviano FH.
Diez BD, et al.
Cancer Chemother Pharmacol. 2010 Mar;65(4):727-34. doi: 10.1007/s00280-009-1078-6. Epub 2009 Jul 30.
Cancer Chemother Pharmacol. 2010.
PMID: 19641919
Free PMC article.
Clinical Trial.